Chronic idiopathic constipation

临床试验

计划入组 211 人 · 首次发布于 2016 年 4 月 6 日

已完成

NCT01429987

The Plecanatide Chronic Idiopathic Constipation (CIC) Study

计划入组 951 人 · 首次发布于 2011 年 9 月 7 日

已完成

NCT02695719

Lubiprostone for Treatment of Chronic Idiopathic Constipation

计划入组 156 人 · 首次发布于 2016 年 3 月 1 日

药物

查看全部 344 →

Small Molecule

Approved

Plecanatide(Trulance)

相关疾病：Irritable Bowel Syndrome With Constipation (IBS-C), Chronic idiopathic constipation (CIC)

C₆₅H₁₀₄N₁₈O₂₆S₄

Small Molecule

Approved

Lactitol(Pizensy)

相关疾病：Constipation, Hepatic Encephalopathy (HE)，另有 2 项

C₁₂H₂₄O₁₁

Small Molecule

Approved

Prucalopride(Motegrity, Resolor, Resotran)

相关疾病：Opioid Induced Constipation (OIC), Chronic idiopathic constipation (CIC)，另有 1 项

C₁₈H₂₆ClN₃O₃ · Rx

机构

查看全部 61 →

Kineta Chronic Pain LLC

United States

PEGBIO CO-B

HARVEST TRAVEL & LEISURE INCOME ETF UNIT CL A

United States

资讯

查看全部 6504 →

5年前

FDA Approves Prucalopride for Chronic Idiopathic Constipation

7个月前

Ardelyx Initiates Phase 3 ACCEL Trial for IBSRELA in Chronic Idiopathic Constipation

去年

临床试验

Lubiprostone for Chronic Idiopathic Constipation Treatment

The Plecanatide Chronic Idiopathic Constipation (CIC) Study

Lubiprostone for Treatment of Chronic Idiopathic Constipation

药物

Plecanatide(Trulance)

Lactitol(Pizensy)

Prucalopride(Motegrity, Resolor, Resotran)

机构

Kineta Chronic Pain LLC

PEGBIO CO-B

HARVEST TRAVEL & LEISURE INCOME ETF UNIT CL A

资讯

FDA Approves Prucalopride for Chronic Idiopathic Constipation

Ardelyx Initiates Phase 3 ACCEL Trial for IBSRELA in Chronic Idiopathic Constipation

Sunshine Biopharma Expands Portfolio with Two Gastrointestinal Drugs for Chronic Idiopathic Constipation